WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 7 fonti

Gilead Applauds Collaborative Efforts to Launch Lenacapavir for HIV Prevention in South Africa

Gilead Applauds Collaborative Efforts to Launch Lenacapavir for HIV Prevention in South Africa

Raccontata dabusinessday.co.zamorningstar.comiol.co.zanpr.orgpublico.esupi.comafricanews.com

Confronto fonti

6 prospettive sulla stessa storia
AI · summaries
morningstar.comStai leggendo1 mesi fa

Gilead Applauds Collaborative Efforts to Launch Lenacapavir for HIV Prevention in South Africa

Gilead Applauds Collaborative Efforts to Launch Lenacapavir for HIV Prevention in South Africa

originale

Timeline cronologica

  1. venerdì 5 giugno 2026·businessday.co.za

    Ramaphosa urged to press for wider access to Gilead’s HIV shot in SA

    Limited supplies threaten potential positive effect of HIV prevention drug lenacapavir

  2. venerdì 5 giugno 2026·morningstar.com

    Gilead Applauds Collaborative Efforts to Launch Lenacapavir for HIV Prevention in South Africa

    Gilead Applauds Collaborative Efforts to Launch Lenacapavir for HIV Prevention in South Africa

iol.co.za
1 mesi fa

Lenacapavir rollout in South Africa: A groundbreaking step in HIV prevention

South Africa's launch of Lenacapavir marks a transformative moment in the fight against HIV, promising to significantly reduce new infections and improve health outcomes for millions.

Leggi questa versione → originale
upi.com1 mesi fa

South Africa rolls out twice-yearly HIV prevention drug - UPI.com

South African officials on Friday announced that the HIV prevention drug Lenacapavir is now available there, calling it a "turning point."

Leggi questa versione → originale
africanews.com1 mesi fa

Ramaphosa hails Lenacapavir roll out as turning point in HIV fight | Africanews

A twice-yearly injectable HIV prevention drug has arrived in South Africa. The rollout of the drug, lenacapavir, is underway in the country that needs it the most, about a-year-and-a-half after US aid cuts hit some of…

Leggi questa versione → originale
businessday.co.za1 mesi fa

Ramaphosa urged to press for wider access to Gilead’s HIV shot in SA

Limited supplies threaten potential positive effect of HIV prevention drug lenacapavir

Leggi questa versione → originale
npr.org1 mesi fa

South Africa rolls out game-changing HIV shot amid funding shortfalls

A new twice-yearly HIV prevention injection could transform South Africa's fight against the epidemic — but U.S. aid cuts and limited doses threaten to slow its impact.

Leggi questa versione → originale
venerdì 5 giugno 2026·iol.co.za

WATCH | Ramaphosa launches rollout of new HIV prevention injection Lenacapavir

The Presidency says Lenacapavir, a twice-yearly HIV prevention injection, will expand biomedical tools in South Africa’s fight against new infections and strengthen long-term…

  • venerdì 5 giugno 2026·businessday.co.za

    WATCH LIVE | Lenacapavir rollout launch

    President Cyril Ramaphosa is on Friday launching the rollout of Lenacapavir, a new injectable prevention for HIV/Aids.

  • venerdì 5 giugno 2026·iol.co.za

    PICS: Ramaphosa launches Lenacapavir rollout, says it offers 'hope' in fight against HIV/AIDS

    President Cyril Ramaphosa has launched South Africa’s rollout of Lenacapavir, a twice-yearly HIV prevention injection aimed at reducing new infections and strengthening the…

  • venerdì 5 giugno 2026·npr.org

    South Africa rolls out game-changing HIV shot amid funding shortfalls

    A new twice-yearly HIV prevention injection could transform South Africa's fight against the epidemic — but U.S. aid cuts and limited doses threaten to slow its impact.

  • venerdì 5 giugno 2026·publico.es

    Sudáfrica califica la distribución del medicamento lenacapavir como un "punto de inflexión" frente al VIH

    La OMS calificó la decisión de extender su uso como histórica y considera que podría redefinir la respuesta global a la epidemia.

  • venerdì 5 giugno 2026·iol.co.za

    South African officially launches twice-yearly Lenacapavir HIV prevention jab

    South Africa officially launched the national rollout of Lenacapavir, a groundbreaking, twice-yearly injectable drug for HIV prevention

  • venerdì 5 giugno 2026·upi.com

    South Africa rolls out twice-yearly HIV prevention drug - UPI.com

    South African officials on Friday announced that the HIV prevention drug Lenacapavir is now available there, calling it a "turning point."

  • sabato 6 giugno 2026·iol.co.za

    Lenacapavir rollout in South Africa: A groundbreaking step in HIV prevention

    South Africa's launch of Lenacapavir marks a transformative moment in the fight against HIV, promising to significantly reduce new infections and improve health outcomes for…

  • sabato 6 giugno 2026·iol.co.za

    What is lenacapavir? Everything you need to know about the HIV prevention injection

    We look at how lenacapavir, a groundbreaking HIV prevention injection, is set to transform the fight against HIV and why it matters for millions worldwide.

  • domenica 7 giugno 2026·iol.co.za

    Gauteng targets 56,000 people as new twice-yearly Lenacapavir HIV prevention rolls out across 133 clinics

    Gauteng is set to roll out Lenacapavir, a new long-acting HIV prevention injection, targeting over 56,000 individuals at high risk of HIV infection.

  • lunedì 8 giugno 2026·africanews.com

    Ramaphosa hails Lenacapavir roll out as turning point in HIV fight | Africanews

    A twice-yearly injectable HIV prevention drug has arrived in South Africa. The rollout of the drug, lenacapavir, is underway in the country that needs it the most, about…